Pioneering Medical Innovations
Menu
Pioneering Medical Innovations
In 1998, MedTech leaders Amar Sawhney and Fred Khosravi recognized a systemic problem in the healthcare industry: while big strategic companies were making incremental advancements in medical devices, technologies, and treatments, they were largely focused on investing in projects that would make the most money for their shareholders, rather than those that had the greatest potential for scale and human impact.
Both Fred and Amar knew that there was a better approach. They believed that by investing in the potential of visionary entrepreneurs, cultivating novel ideas designed to solve the most difficult healthcare challenges, and measuring success based on lives impacted, rather than just dollars earned, they would not only accelerate the pace of innovation—but also rapidly elevate the quality and effectiveness of healthcare overall.
Since its founding, Incept’s unique purpose-driven approach has helped its companies raise over $1.4 billon in development and venture financing, leading to over $6 billion of aggregate returns to their shareholders. But more importantly than that, the devices and technology created by its companies treat over 1.3 million patients every year, and have transformed the industry—and the world—for the better.
Today, every decision Incept makes, and every company it fosters, are rooted in the same guiding principles on which it was built:
It’s because of these unwavering standards that Incept continues to lead the way in the MedTech innovation field, with unlimited potential to radically change the paradigm of healthcare, and improve the lives of patients and families everywhere.
